LU AA 24493
N/A
Report date: 2022/08/29 20:00:24
Base Information
Drug NameLU AA 24493
Drug Alias Name +[6]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[5]
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesWarren Pharmaceuticals
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesNational Institute Of Neurological Disorders And StrokeH. Lundbeck A/S
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A